Literature DB >> 16123531

Predictors of the early 5-year course of schizophrenia: a path analysis.

Marie E Lenior1, Peter M A J Dingemans, Aart H Schene, Don H Linszen.   

Abstract

In this study, the effect of 19 possible predictor variables on 4 outcome variables was analyzed in young patients with recent-onset schizophrenia and related disorders (n = 64). Patients who participated in a 15-month intervention program were stratified into low and high parental expressed emotion and randomized over two intervention conditions: standard intervention and standard plus family intervention. Baseline variables were measured during the intervention. Outcome variables were measured over 5 years after discharge and comprised duration of psychotic episodes, living institutions for psychiatric patients, structural activities, and help from the family. From the 19 baseline variables, 6 had possible predictive value and were entered in a multivariate analysis. The resulting path model indicated that the score on the Strauss and Carpenter prognostic scale was predictive for duration of psychotic episodes. Diagnosis (schizophrenia vs. schizophrenia-related disorder) predicted help from the family. Age at first psychotic episode predicted living in institutions for psychiatric patients. Duration of psychotic episodes was associated with living in institutions for psychiatric patients and with help from the family but not with structural activities.

Entities:  

Mesh:

Year:  2005        PMID: 16123531     DOI: 10.1093/schbul/sbi010

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  4 in total

Review 1.  Aripiprazole in adolescents with schizophrenia: profile report.

Authors:  Mark Sanford; Gillian M Keating
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 2.  Early intervention for psychosis.

Authors:  Max Marshall; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 3.  Parenting interventions for people with schizophrenia or related serious mental illness.

Authors:  Jessica Radley; Claire Grant; Jane Barlow; Louise Johns
Journal:  Cochrane Database Syst Rev       Date:  2021-10-19

Review 4.  Aripiprazole: in adolescents with schizophrenia.

Authors:  Mark Sanford; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.